Skip Ribbon Commands
Skip to main content

Title

Immune mediated destruction of central nervous system diseases

Status

Open

Project Description

 

In the past few years, several new efficacious therapies have emerged for treatment of patients with neuroimmunological disorders such as Multiple Sclerosis (MS) and Neuromyelitis Optica (NMO). As a translational research lab, we are focused on the mechanisms of action of these therapeutics, as well as discovering potential novel therapies for patients with neuroimmunological disorders including MS, NMO and others.  Our lab focuses on immune mechanisms mediating neurological disorders to further understand how immune cells orchestrate disease initiation, progression, stability, and remission. We study innate and adaptive human immune cells and their ability to communicate with (activate or repress) cells within the brain and central nervous system in the context of disease. The results from our studies will potentially lead to a better understanding of the current and emerging therapies in neuroimmunological disorders providing rationale for combination therapies or novel therapeutics for effected patient populations.

 

Mentor Name

Jackson, Leila

Mentor Location

12700 East 19th Ave

Mentor Contact Number

303-724-4556

Mentor Contact Email

leila.jackson@ucdenver.edu

Specialty

Enter Choice #1

Preceptor Name

 

Student

 

Department

Neurology

Funding Department/Program

Neurology

Area of Study

Immunology and Autoimmune Diseases; Neuroscience, Brain and Behavior - Adult

Populations

Adults

Method(s)

Animal Models; Cell Biology, Molecular Biology, and Genetics; Clinical Trials

Disease or Symptom

Multiple Sclerosis

Faculty/Lab Website

 

Display on public listings?

Yes

Attachments

Created at 7/11/2012 4:55 PM by Watts, Katie
Last modified at 7/9/2013 1:55 PM by Watts, Katie